The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Adams A.C., H. L., Solmaz Sobhanifar(AbCellera (Canada)), Rocío Laguna Goya, Roza Bidshahri(AbCellera (Canada)), J. Hendle(Eli Lilly (United States)), Meike Dittmann(New York University), Martinez D.R.(University of North Carolina at Chapel Hill), Krithika Muthuraman(AbCellera (Canada)), Baric R.S(University of North Carolina at Chapel Hill), Viktoriya Borisevich(Galveston College), Kerstin Westendorf(La Jolla Institute for Immunology), You Mi Hwang, Olubukola M. Abiona(National Institutes of Health), D. Wrapp, Letícia Kraft, John R. Mascola(National Institute of Allergy and Infectious Diseases), Ahmad Rithauddin Mohamed, Julian Davies(Eli Lilly (United States)), Higgs R.E, Geisbert T.W., Belli H.M., Barnhart B.C., Yi Zhang(National Institutes of Health), Smith M.A, Goldsmith J.A., Lin Wang(Qingdao University), Yang E.S, Samanovic M.I., Corbett K.S, Mulligan M.J., Cujec T.P, Wiethoff C.M, Heinz B.A, Jepson K.R, Tycho S.A, Brown-Augsburger P.L, Hinshaw S.J, Blackbourne J.L, Jones B.E, Cross R.W., Hsieh C.-L., Johnson N.V., Collins D.W, Piper M.H, Triana F.J, Berens S.J., Deepa Balasubramaniam(Eli Lilly (United States)), McLellan J.S., Davide Pellacani(AbCellera (Canada))
UNC Libraries
June 12, 2024
Cited by 0


Related Papers